Waldenstrom Macroglobulinemia Therapeutics Market Report

Global and Region Waldenstrom Macroglobulinemia Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：214
  • REPORT CODE：GMM964109
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Waldenstrom Macroglobulinemia Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Waldenstrom Macroglobulinemia Therapeuticsmarket, defines the market attractiveness level of Waldenstrom Macroglobulinemia Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Waldenstrom Macroglobulinemia Therapeutics industry, describes the types of Waldenstrom Macroglobulinemia Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Waldenstrom Macroglobulinemia Therapeutics market and the development prospects and opportunities of Waldenstrom Macroglobulinemia Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Waldenstrom Macroglobulinemia Therapeutics market in Chapter 13.

    By Player:

    • IGF Oncology, LLC

    • Celgene Corporation

    • Genmab A/S

    • Hutchison MediPharma Limited

    • Genentech, Inc

    • Idera Pharmaceuticals, Inc

    • Gilead Sciences, Inc

    • BeiGene(Beijing) Co,Ltd

    • Merck KGaA

    • Incyte Corporation

    • Karyopharm Therapeutics, Inc

    • Calithera Biosciences, Inc

    • Millennium Pharmaceuticals, Inc

    By Type:

    • CB-839

    • Copanlisib Hydrochloride

    • DI-B4

    • Entospletinib

    • Everolimus

    • FV-162

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Waldenstrom Macroglobulinemia Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Waldenstrom Macroglobulinemia Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Waldenstrom Macroglobulinemia Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Waldenstrom Macroglobulinemia Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Waldenstrom Macroglobulinemia Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    • 7.2 United States Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    • 7.3 Europe Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    • 7.4 China Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    • 7.5 Japan Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    • 7.6 India Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Waldenstrom Macroglobulinemia Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Waldenstrom Macroglobulinemia Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast (2022-2028)

    9 Global Waldenstrom Macroglobulinemia Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CB-839 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Copanlisib Hydrochloride Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global DI-B4 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Entospletinib Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Everolimus Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global FV-162 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Waldenstrom Macroglobulinemia Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CB-839 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Copanlisib Hydrochloride Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global DI-B4 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Entospletinib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global FV-162 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Waldenstrom Macroglobulinemia Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Waldenstrom Macroglobulinemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Waldenstrom Macroglobulinemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Waldenstrom Macroglobulinemia Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Waldenstrom Macroglobulinemia Therapeutics Market Competitive Analysis

    • 14.1 IGF Oncology, LLC

      • 14.1.1 IGF Oncology, LLC Company Details

      • 14.1.2 IGF Oncology, LLC Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 IGF Oncology, LLC Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.2 Celgene Corporation

      • 14.2.1 Celgene Corporation Company Details

      • 14.2.2 Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.3 Genmab A/S

      • 14.3.1 Genmab A/S Company Details

      • 14.3.2 Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.4 Hutchison MediPharma Limited

      • 14.4.1 Hutchison MediPharma Limited Company Details

      • 14.4.2 Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.5 Genentech, Inc

      • 14.5.1 Genentech, Inc Company Details

      • 14.5.2 Genentech, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Genentech, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.6 Idera Pharmaceuticals, Inc

      • 14.6.1 Idera Pharmaceuticals, Inc Company Details

      • 14.6.2 Idera Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Idera Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.7 Gilead Sciences, Inc

      • 14.7.1 Gilead Sciences, Inc Company Details

      • 14.7.2 Gilead Sciences, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Gilead Sciences, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.8 BeiGene(Beijing) Co,Ltd

      • 14.8.1 BeiGene(Beijing) Co,Ltd Company Details

      • 14.8.2 BeiGene(Beijing) Co,Ltd Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BeiGene(Beijing) Co,Ltd Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.9 Merck KGaA

      • 14.9.1 Merck KGaA Company Details

      • 14.9.2 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.10 Incyte Corporation

      • 14.10.1 Incyte Corporation Company Details

      • 14.10.2 Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.11 Karyopharm Therapeutics, Inc

      • 14.11.1 Karyopharm Therapeutics, Inc Company Details

      • 14.11.2 Karyopharm Therapeutics, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Karyopharm Therapeutics, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.12 Calithera Biosciences, Inc

      • 14.12.1 Calithera Biosciences, Inc Company Details

      • 14.12.2 Calithera Biosciences, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Calithera Biosciences, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • 14.13 Millennium Pharmaceuticals, Inc

      • 14.13.1 Millennium Pharmaceuticals, Inc Company Details

      • 14.13.2 Millennium Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Millennium Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Waldenstrom Macroglobulinemia Therapeutics

    • Figure Waldenstrom Macroglobulinemia Therapeutics Picture

    • Table Global Waldenstrom Macroglobulinemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Waldenstrom Macroglobulinemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Waldenstrom Macroglobulinemia Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Waldenstrom Macroglobulinemia Therapeutics Consumption by Country (2017-2022)

    • Figure United States Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Waldenstrom Macroglobulinemia Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Waldenstrom Macroglobulinemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CB-839 Consumption and Growth Rate (2017-2022)

    • Figure Global Copanlisib Hydrochloride Consumption and Growth Rate (2017-2022)

    • Figure Global DI-B4 Consumption and Growth Rate (2017-2022)

    • Figure Global Entospletinib Consumption and Growth Rate (2017-2022)

    • Figure Global Everolimus Consumption and Growth Rate (2017-2022)

    • Figure Global FV-162 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CB-839 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Copanlisib Hydrochloride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DI-B4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Entospletinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global FV-162 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Waldenstrom Macroglobulinemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Waldenstrom Macroglobulinemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table IGF Oncology, LLC (Foundation Year, Company Profile and etc.)

    • Table IGF Oncology, LLC Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table IGF Oncology, LLC Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Genmab A/S (Foundation Year, Company Profile and etc.)

    • Table Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Hutchison MediPharma Limited (Foundation Year, Company Profile and etc.)

    • Table Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Genentech, Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Idera Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Idera Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Idera Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table BeiGene(Beijing) Co,Ltd (Foundation Year, Company Profile and etc.)

    • Table BeiGene(Beijing) Co,Ltd Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeiGene(Beijing) Co,Ltd Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Incyte Corporation (Foundation Year, Company Profile and etc.)

    • Table Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Karyopharm Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Karyopharm Therapeutics, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Karyopharm Therapeutics, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Calithera Biosciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Calithera Biosciences, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Calithera Biosciences, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service

    • Table Millennium Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Millennium Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Millennium Pharmaceuticals, Inc Waldenstrom Macroglobulinemia Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US